Expanding the diagnosis of pediatric bacteremic pneumococcal pneumonia from blood cultures to molecular methods: Advantages and caveats

Clinical Infectious Diseases

Volumn 51, Issue 9, 2010, Pages 1050-1052

  Ramirez, Mário ^a   Melo Cristino, José ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b Centro Hospitalar Lisboa Norte   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD CULTURE; BLOOD SAMPLING; COMMUNITY ACQUIRED PNEUMONIA; GOLD STANDARD; HUMAN; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROTYPING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; PNEUMONIA, PNEUMOCOCCAL; POLYMERASE CHAIN REACTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 77958570254     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656580     Document Type: Note

References (14)

1. Avni T, Mansur N, Leibovici L, Paul M. PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol 2010; 48:489-496.
2. Charkaluk ML, Kalach N, Mvogo H, et al. Assessment of a rapid urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal infection in children. Diagn Microbiol Infect Dis 2006; 55:89-94. (Pubitemid 43792404)
3. Dowell SF, Garman RL, Liu G, Levine OS, Yang YH. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis 2001; 32:824-825.
4. Resti M, Moriondo M, Cortimiglia M, et al. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis 2010; 51(9):1042-1049 (in this issue).
5. Kellogg JA, Bankert DA, Elder CJ, Gibbs JL, Smith MC. Identification of Streptococcus pneumoniae revisited. J Clin Microbiol 2001; 39:3373-3375.
6. Connell TG, Rele M, Cowley D, Buttery JP, Curtis N. How reliable is a negative blood culture result? volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 2007; 119:891-896.
7. Gonsalves WI, Cornish N, Moore M, Chen A, Varman M. Effects of volume and site of blood draw on blood culture results. J Clin Microbiol 2009; 47:3482-3485.
8. Baron EJ, ed. Cumitech #1c Blood Cultures IV. Washington, DC: American Society for Microbiology, 2005.
9. Knoll MD, Moisi JC, Muhib FB, et al. Standardizing surveillance of pneumococcal disease. Clin Infect Dis 2009; 48(Suppl 2):S37-S48.
10. Whatmore AM, Efstratiou A, Pickerill AP, et al. Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of "atypical" pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect Immun 2000; 68:1374-1382.
11. Carvalho MG, Tondella ML, McCaustland K, et al. Evaluation and improvement of realtime PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 2007; 45:2460-2466.
12. Dagan R, Shriker O, Hazan I, et al. Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol 1998; 36:669-673.
13. Michelow IC, Lozano J, Olsen K, et al. Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis 2002; 34:E1-E11.
14. Aguiar SI, Brito MJ, Gonçalo-Marques J, Melo-Cristino J, Ramirez M. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 2010; 28(32):5167-5173.